Ticker Details
INmune Bio Inc. Common stock
IPO Date:	February 4, 2019
Sector:	Healthcare
Industry:	Biotechnology
Market Cap:	$38.55M
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.33 | 3.84%
Avg Daily Range (30 D):	$0.06 | 3.90%
Avg Daily Range (90 D):	$0.05 | 3.60%

Institutional Daily Volume
Avg Daily Volume:	.31M
Avg Daily Volume (30 D):	.38M
Avg Daily Volume (90 D):	.41M

Trade Size
Avg Trade Size (Sh.):	135
Avg Trade Size (Sh.) (30 D):	161
Avg Trade Size (Sh.) (90 D):	161

Institutional Trades
Total Institutional Trades:	26
Avg Institutional Trade:	$1.45M
Avg Institutional Trade (30 D):	$2M
Avg Institutional Trade (90 D):	$2M
Avg Institutional Trade Volume:	.12M
Avg Institutional Trades (Per Day):	1

Market Closing Trades
Avg Closing Trade:	$1.74M
Avg Closing Trade (30 D):	$2M
Avg Closing Trade (90 D):	$2M
Avg Closing Volume:	185.19K

News

May 15, 2026 @ 12:00 PM INmune Bio Publishes Phase 2 MINDFuL Trial Results... Source: Na

May 14, 2026 @ 12:00 PM INmune Bio Receives FDA Fast Track Designation for... Source: Inmune Bio Inc.

May 7, 2026 @ 8:00 PM INmune Bio Inc. Announces First Quarter 2026 Resul... Source: Inmune Bio Inc.

Apr 30, 2026 @ 12:00 PM INmune Bio Inc. to Report First Quarter 2026 Finan... Source: Na

Mar 19, 2026 @ 12:00 PM INmune Bio’s MINDFuL Trial Featured at AD/P... Source: Inmune Bio Inc.

Financials
	TTM	Q1 2026	Q4 2025
Basic EPS	$-1.67	$-.2	$-.18
Diluted EPS	$-1.67	$-.2	$-.18
Revenue	$M	$M	$M
Gross Profit
Net Income / Loss	$-41.6M	$-5.41M	$-5.26M
Operating Income / Loss	$-43.29M	$-5.81M	$-5.47M
Cost of Revenue
Net Cash Flow	$3.63M	$-3.39M	$-6.65M
PE Ratio